Using genetics of human fat cells to predict response to anti-diabetes drugs

Researchers have demonstrated — using fat cells derived from human stem cells — that individual genetic variation can be used to predict whether the TZD rosiglitazone will produce the unwanted side effect of increasing cholesterol levels in certain individuals.

Leave a Reply

Your email address will not be published. Required fields are marked *